Veterinary Medicines

NEOPRIDIMET ORALE, 600 mg/g +120 mg/g, premiscela per alimenti medicamentosi per suini e salmonidi

Authorised
  • Sulfadiazine
  • Trimethoprim
Download as PDF

Product identification

Medicine name:
NEOPRIDIMET ORALE, 600 mg/g +120 mg/g, premiscela per alimenti medicamentosi per suini e salmonidi
Active substance:
  • Sulfadiazine
  • Trimethoprim
Target species:
  • Pig
  • Salmonid
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Sulfadiazine
    600.00
    milligram(s)
    /
    1.00
    gram(s)
  • Trimethoprim
    120.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • In-feed use
    • Pig
      • Meat and offal
        3
        day
    • Salmonid
      • Meat and offal
        250
        degree day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EW10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 103546
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 13/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."